Antimicrobial Resistance Diagnostics Market Trends and Growth 2034
Global Antimicrobial Resistance Diagnostics Market Growth, Size, Trends Analysis - By Product Type, By Technology, By Pathogen Type, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: Sep-2025 | Report ID: HLCA25277 | Pages: 1 - 262 | Formats*: |
| Category : Healthcare | |||
Global Antimicrobial Resistance Diagnostics Market Introduction and Overview
According to SPER Market Research, the Global Antimicrobial Resistance Diagnostics Market is estimated to reach USD 8.85 billion by 2034 with a CAGR of 6.56%.
The report includes an in-depth analysis of the Global Antimicrobial Resistance Diagnostics Market, including market size and trends, product mix, Applications, and supplier analysis. The worldwide market for antimicrobial resistance diagnostics was assessed at USD 4.69 billion in 2024 and is projected to experience a compound annual growth rate (CAGR) exceeding 6.56% from 2025 to 2034. The global demand for antimicrobial resistance diagnostics is swiftly increasing due to the rise of antibiotic-resistant infections, the heightened requirement for precision medicine, and advancements in diagnostic technologies.
By Product Type Insights
The market is divided into two product categories: instruments & consumables and kits & reagents. In 2024, the kits & reagents segment led the market. The identification of antimicrobial resistance (AMR) requires the precise and rapid detection of resistant bacterial strains, which is facilitated by kits and reagents. Prompt diagnosis is essential for administering the appropriate treatment early on, thereby preventing the inappropriate use of antibiotics that contribute to resistance. The demand for AMR diagnostic kits and reagents is further enhanced by both international and national initiatives.
By Technology Insights
In terms of technology, the antimicrobial resistance diagnostic market is divided into microbiology culture, immunoassay, polymerase chain reaction (PCR), next generation sequencing (NGS), mass spectrometry, rapid & point of care, and other technologies. The microbiology culture segment represented a substantial share of the market in 2024. Technological advancements in microbial culture have significantly accelerated the speed, accuracy, and specificity of resistant strain detection. Diagnoses can now be completed in hours rather than days, thanks to faster automated culture system platforms such as the BD Phoenix or Vitek. Furthermore, the prevailing trends suggest a conducive environment for culture-based diagnostics of antibiotic-resistant bacteria, which is expected to drive market growth.
By Pathogen Type Insights
Regarding pathogen type, the antimicrobial resistance diagnostic market is classified into drug-resistant streptococcus pneumoniae (DRSP), drug-resistant campylobacter (DRC), clostridium difficile (CD), drug-resistant Neisseria gonorrhoeae (DRNG), and other pathogen types. The clostridium difficile segment was the market leader in 2024. C. Difficile is a leading cause of healthcare-associated infections (HAIs) and predominantly affects hospitalized patients and the elderly. The presence of comorbidities in older patients contributes to rising infection rates.
Regional Insights
The global market for antimicrobial resistance diagnostics in 2024 was dominated by North America. The region's growth can be attributed to various factors, including the heightened risk of antimicrobial resistance, supportive governmental initiatives aimed at combating AMR, and the presence of sophisticated healthcare infrastructure. Furthermore, the existence of key market players and their strategic initiatives are anticipated to further propel segment growth in the forthcoming years. Collectively, these factors foster a favorable environment for the development and implementation of innovative solutions in the battle against antimicrobial resistance.
Market Competitive Landscape
The global market for diagnosing antimicrobial resistance features numerous competing suppliers, prompting manufacturers to explore ways to address the ongoing AMR challenge. Leading companies offer a wide range of diagnostic products, such as molecular diagnostics and point-of-care (POC) diagnostics. They invest substantial capital in acquiring the most efficient measurement reporting units in the shortest time frame, while also maximizing the number of identified pathogens. Additionally, the establishment of partnerships between companies for strategic collaboration is facilitated, allowing them to leverage next-generation sequencing (NGS) and other PCR-based diagnostic kits to broaden their product offerings.
Recent Developments:
FIND and the Kingdom of Saudi Arabia announced in October 2024 that they will be hosting a high-level side event to discuss the shortcomings in AMR diagnosis. This program is intended to combat AMR and is expected to increase the organization's presence in uncharted markets.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Product Type, By Technology, By Pathogen Type, By End User |
| Regions covered | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa |
| Companies Covered | Abbott Laboratories, Accelerated Diagnostics, USA, Alifax, Bio-Rad Laboratories, BioMerieux, Beckman Coulter, Becton, Dickinson and Company, F. Hoffmann-La Roche, GeneFluidics, Molsid. |
Key Topics Covered in the Report
- Global Antimicrobial Resistance Diagnostics Market Size (FY’2021-FY’2034)
- Overview of Global Antimicrobial Resistance Diagnostics Market
- Segmentation of Global Antimicrobial Resistance Diagnostics Market By Product Type (Kits & reagents, Instruments & consumables)
- Segmentation of Global Antimicrobial Resistance Diagnostics Market By Technology (Microbiology culture, Immunoassay, Polymerase chain reaction, Next generation sequencing, Mass spectrometry, Rapid & point of care, other technologies)
- Segmentation of Global Antimicrobial Resistance Diagnostics Market By Pathogen Type (Drug-resistant streptococcus pneumoniae, Drug-resistant campylobacter, Clostridium difficile, Drug-resistant Neisseria gonorrhoeae, other pathogen types)
- Segmentation of Global Antimicrobial Resistance Diagnostics Market By End-User (Hospitals & clinics, Diagnostic laboratories, Pharmaceutical & biotechnology companies, other end user)
- Statistical Snap of Global Antimicrobial Resistance Diagnostics Market
- Expansion Analysis of Global Antimicrobial Resistance Diagnostics Market
- Problems and Obstacles in Global Antimicrobial Resistance Diagnostics Market
- Competitive Landscape in the Global Antimicrobial Resistance Diagnostics Market
- Details on Current Investment in Global Antimicrobial Resistance Diagnostics Market
- Competitive Analysis of Global Antimicrobial Resistance Diagnostics Market
- Prominent Players in the Global Antimicrobial Resistance Diagnostics Market
- SWOT Analysis of Global Antimicrobial Resistance Diagnostics Market
- Global Antimicrobial Resistance Diagnostics Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1.Introduction
1.1.Scope of the report1.2.Market segment analysis
2.Research Methodology
2.1.Research data source
2.1.1.Secondary Data2.1.2.Primary Data2.1.3.SPERs internal database2.1.4.Premium insight from KOLs
2.2.Market size estimation
2.2.1.Top-down and Bottom-up approach
2.3.Data triangulation
3.Executive Summary
4.Market Dynamics
4.1.Driver, Restraint, Opportunity and Challenges analysis
4.1.1.Drivers4.1.2.Restraints4.1.3.Opportunities4.1.4.Challenges
5.Market variable and outlook
5.1.SWOT Analysis
5.1.1.Strengths5.1.2.Weaknesses5.1.3.Opportunities5.1.4.Threats
5.2.PESTEL Analysis
5.2.1.Political Landscape5.2.2.Economic Landscape5.2.3.Social Landscape5.2.4.Technological Landscape5.2.5.Environmental Landscape5.2.6.Legal Landscape
5.3.PORTERs Five Forces
5.3.1.Bargaining power of suppliers5.3.2.Bargaining power of buyers5.3.3.Threat of Substitute5.3.4.Threat of new entrant5.3.5.Competitive rivalry
5.4.Heat Map Analysis
6.Competitive Landscape
6.1.Global Antimicrobial Resistance Diagnostics Market Manufacturing Base Distribution, Sales Area, Product Type6.2.Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Antimicrobial Resistance Diagnostics Market
7.Global Antimicrobial Resistance Diagnostics Market, By Product Type (USD Million) 2021-2034
7.1.Kits & reagents7.2.Instruments & consumables
8.Global Antimicrobial Resistance Diagnostics Market, By Technology (USD Million) 2021-2034
8.1.Microbiology culture8.2.Immunoassay8.3.Polymerase chain reaction (PCR)8.4.Next generation sequencing (NGS)8.5.Mass spectrometry8.6.Rapid & point of care8.7.Other technologies
9.Global Antimicrobial Resistance Diagnostics Market, By Pathogen Type (USD Million) 2021-2034
9.1.Drug-resistant streptococcus pneumoniae (DRSP)9.2.Drug-resistant campylobacter (DRC)9.3.Clostridium difficile (CD)9.4.Drug-resistant Neisseria gonorrhoeae (DRNG)9.5.Other pathogen types
10.Global Antimicrobial Resistance Diagnostics Market, By End-User (USD Million) 2021-2034
10.1.Hospitals & clinics10.2.Diagnostic laboratories10.3.Pharmaceutical & biotechnology companies10.4.Other end user
11.Global Antimicrobial Resistance Diagnostics Market, (USD Million) 2021-2034
11.1.Global Antimicrobial Resistance Diagnostics Market Size and Market Share
12.Global Antimicrobial Resistance Diagnostics Market, By Region, (USD Million) 2021-2034
12.1.Asia-Pacific
12.1.1.Australia12.1.2.China12.1.3.India12.1.4.Japan12.1.5.South Korea12.1.6.Rest of Asia-Pacific
12.2.Europe
12.2.1.France12.2.2.Germany12.2.3.Italy12.2.4.Spain12.2.5.United Kingdom12.2.6.Rest of Europe
12.3.Middle East and Africa
12.3.1.Kingdom of Saudi Arabia12.3.2.United Arab Emirates12.3.3.Qatar12.3.4.South Africa12.3.5.Egypt12.3.6.Morocco12.3.7.Nigeria12.3.8.Rest of Middle-East and Africa
12.4.North America
12.4.1.Canada12.4.2.Mexico12.4.3.United States
12.5.Latin America
12.5.1.Argentina12.5.2.Brazil12.5.3.Rest of Latin America
13.Company Profile
13.1.Abbott Laboratories
13.1.1.Company details13.1.2.Financial outlook13.1.3.Product summary13.1.4.Recent developments
13.2.Accelerated Diagnostics, USA
13.2.1.Company details13.2.2.Financial outlook13.2.3.Product summary13.2.4.Recent developments
13.3.Alifax
13.3.1.Company details13.3.2.Financial outlook13.3.3.Product summary13.3.4.Recent developments
13.4.Bio-Rad Laboratories
13.4.1.Company details13.4.2.Financial outlook13.4.3.Product summary13.4.4.Recent developments
13.5.BioMerieux
13.5.1.Company details13.5.2.Financial outlook13.5.3.Product summary13.5.4.Recent developments
13.6.Beckman Coulter
13.6.1.Company details13.6.2.Financial outlook13.6.3.Product summary13.6.4.Recent developments
13.7.Becton, Dickinson and Company
13.7.1.Company details13.7.2.Financial outlook13.7.3.Product summary13.7.4.Recent developments
13.8.F. Hoffmann-La Roche
13.8.1.Company details13.8.2.Financial outlook13.8.3.Product summary13.8.4.Recent developments
13.9.GeneFluidics
13.9.1.Company details13.9.2.Financial outlook13.9.3.Product summary13.9.4.Recent developments
13.10.Molsid
13.10.1.Company details13.10.2.Financial outlook13.10.3.Product summary13.10.4.Recent developments
13.11.Others
14.Conclusion
15.List of Abbreviations
16.Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Antimicrobial Resistance Diagnostics Market is projected to reach USD 8.85 billion by 2034, growing at a CAGR of 6.56% during the forecast period.
Antimicrobial Resistance Diagnostics Market size from 2025. The Market is expected to reach USD 8.85 billion by 2034, at a CAGR of 6.56% during the forecast period.
Antimicrobial Resistance Diagnostics Market CAGR of 6.56% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Antimicrobial Resistance Diagnostics Market size is USD 8.85 billion from 2025 to 2034.
Antimicrobial Resistance Diagnostics Market covered By Product Type, By Technology, By Pathogen Type, By End User
The North America is anticipated to have the highest Market share in the Antimicrobial Resistance Diagnostics Market.
Abbott Laboratories, Accelerated Diagnostics, USA, Alifax, Bio-Rad Laboratories, BioMerieux, Beckman Coulter, Becton, Dickinson and Company, F. Hoffmann-La Roche, GeneFluidics, Molsid.
The report includes an in-depth analysis of the Global Antimicrobial Resistance Diagnostics Market, including market size and trends, product mix, Applications, and supplier analysis.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
